Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1848 2
1849 1
1853 3
1854 1
1856 5
1857 1
1858 3
1859 1
1860 1
1861 1
1863 1
1866 3
1867 5
1868 6
1869 2
1870 3
1871 3
1872 1
1873 1
1874 3
1876 2
1877 2
1878 1
1879 3
1880 4
1881 8
1882 22
1883 9
1884 11
1885 9
1886 11
1887 6
1888 14
1889 21
1890 24
1891 33
1892 28
1893 15
1894 29
1895 33
1896 33
1897 32
1898 49
1899 62
1900 40
1901 72
1902 51
1903 47
1904 69
1905 65
1906 60
1907 77
1908 77
1909 97
1910 80
1911 61
1912 89
1913 129
1914 110
1915 75
1916 59
1917 49
1918 58
1919 59
1920 55
1921 65
1922 62
1923 70
1924 69
1925 77
1926 63
1927 100
1928 73
1929 70
1930 80
1931 80
1932 77
1933 74
1934 79
1935 66
1936 77
1937 73
1938 66
1939 72
1940 56
1941 72
1942 66
1943 79
1944 109
1945 705
1946 1502
1947 1906
1948 2279
1949 2197
1950 3785
1951 4030
1952 4674
1953 4790
1954 4273
1955 3908
1956 3694
1957 3501
1958 2939
1959 2617
1960 2652
1961 2523
1962 2492
1963 3429
1964 3990
1965 3147
1966 2998
1967 3455
1968 3708
1969 3503
1970 3331
1971 3600
1972 3510
1973 3525
1974 3610
1975 3213
1976 2996
1977 2965
1978 2943
1979 3093
1980 2949
1981 3017
1982 3411
1983 3471
1984 3648
1985 3756
1986 3932
1987 3903
1988 3876
1989 4555
1990 4940
1991 4957
1992 5024
1993 5621
1994 5974
1995 6506
1996 6844
1997 6929
1998 7575
1999 7692
2000 8018
2001 8724
2002 9563
2003 10178
2004 10861
2005 11675
2006 12693
2007 13496
2008 14115
2009 14599
2010 15814
2011 17591
2012 18782
2013 19804
2014 21429
2015 22193
2016 22864
2017 23055
2018 23934
2019 25469
2020 27248
2021 26859
2022 23516
2023 21672
2024 10774

Text availability

Article attribute

Article type

Publication date

Search Results

607,505 results

Results by year

Filters applied: . Clear all
Page 1
Drug resistant TB - latest developments in epidemiology, diagnostics and management.
Tiberi S, Utjesanovic N, Galvin J, Centis R, D'Ambrosio L, van den Boom M, Zumla A, Migliori GB. Tiberi S, et al. Int J Infect Dis. 2022 Nov;124 Suppl 1:S20-S25. doi: 10.1016/j.ijid.2022.03.026. Epub 2022 Mar 25. Int J Infect Dis. 2022. PMID: 35342000 Free article. Review.
AIM: The aim of this review is to inform the reader on the latest developments in epidemiology, diagnostics and management. EPIDEMIOLOGY: Drug-resistant Tuberculosis (DR-TB) continues to be a current global health threat, and is defined by higher morbidity and mortality, s …
AIM: The aim of this review is to inform the reader on the latest developments in epidemiology, diagnostics and management. EPIDEMIOLOGY: Dr …
Drug-resistant Spinal Tuberculosis.
Jain AK, Jaggi KR, Bhayana H, Saha R. Jain AK, et al. Indian J Orthop. 2018 Mar-Apr;52(2):100-107. doi: 10.4103/ortho.IJOrtho_306_17. Indian J Orthop. 2018. PMID: 29576636 Free PMC article. Review.
Drug-resistant spinal tuberculosis (TB) is an emerging health problem in both developing and developed countries. ...The conventional culture of Mycobacterium tuberculosis remains the gold standard for both bacteriological diagnosis and drug sensitivity …
Drug-resistant spinal tuberculosis (TB) is an emerging health problem in both developing and developed countries. ...The conventional …
Multidrug-resistant tuberculosis.
Dheda K, Mirzayev F, Cirillo DM, Udwadia Z, Dooley KE, Chang KC, Omar SV, Reuter A, Perumal T, Horsburgh CR Jr, Murray M, Lange C. Dheda K, et al. Nat Rev Dis Primers. 2024 Mar 24;10(1):22. doi: 10.1038/s41572-024-00504-2. Nat Rev Dis Primers. 2024. PMID: 38523140 Review.
Tuberculosis (TB) remains the foremost cause of death by an infectious disease globally. Multidrug-resistant or rifampicin-resistant TB (MDR/RR-TB; resistance to rifampicin and isoniazid, or rifampicin alone) is a burgeoning public health challenge in several parts of the …
Tuberculosis (TB) remains the foremost cause of death by an infectious disease globally. Multidrug-resistant or rifampicin-resistant …
Epidemiology of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: A systematic review and meta-analysis.
Diriba G, Alemu A, Yenew B, Tola HH, Gamtesa DF, Mollalign H, Eshetu K, Moga S, Abdella S, Tollera G, Kebede A, Dangisso MH. Diriba G, et al. Int J Infect Dis. 2023 Jul;132:50-63. doi: 10.1016/j.ijid.2023.04.392. Epub 2023 Apr 16. Int J Infect Dis. 2023. PMID: 37072053 Free PMC article.
OBJECTIVES: To estimate the pooled proportion of extensively drug-resistant tuberculosis (XDR-TB) and pre-extensively drug-resistant tuberculosis (pre-XDR-TB) in patients with multidrug-resistant TB (MDR-TB). ...The high burdens of pre-XD …
OBJECTIVES: To estimate the pooled proportion of extensively drug-resistant tuberculosis (XDR-TB) and pre-extensively …
Pre-extensively drug-resistant tuberculosis among multidrug-resistant tuberculosis patients in Ethiopia: a laboratory-based surveillance study.
Diriba G, Alemu A, Tola HH, Yenew B, Amare M, Eshetu K, Sinshaw W, Abebaw Y, Meaza A, Seid G, Moga S, Zerihun B, Getu M, Dagne B, Mollalign H, Tadesse M, Buta B, Wordofa N, Alemu E, Erresso A, Hailu M, Tefera Z, Wondimu A, Belhu T, Gamtesa DF, Getahun M, Kebede A, Abdela S. Diriba G, et al. IJID Reg. 2022 Aug 30;5:39-43. doi: 10.1016/j.ijregi.2022.08.012. eCollection 2022 Dec. IJID Reg. 2022. PMID: 36176268 Free PMC article.
Understanding the epidemiology of pre-extensively drug-resistant tuberculosis (pre-XDR-TB) could help clinicians to adapt MDR-TB treatment regimens at an earlier stage. This study aimed to assess second-line anti-TB drug resistance …
Understanding the epidemiology of pre-extensively drug-resistant tuberculosis (pre-XDR-TB) could help cli …
Global treatment outcomes of extensively drug-resistant tuberculosis in adults: A systematic review and meta-analysis.
Pedersen OS, Holmgaard FB, Mikkelsen MKD, Lange C, Sotgiu G, Lillebaek T, Andersen AB, Wejse CM, Dahl VN. Pedersen OS, et al. J Infect. 2023 Sep;87(3):177-189. doi: 10.1016/j.jinf.2023.06.014. Epub 2023 Jun 23. J Infect. 2023. PMID: 37356629 Free article. Review.
INTRODUCTION: Historically, extensively drug-resistant tuberculosis has been notoriously difficult to treat with devasting outcomes. ...Furthermore, 25 studies reported outcomes for 3564 individuals with pre-extensively drug-resistant tubercu …
INTRODUCTION: Historically, extensively drug-resistant tuberculosis has been notoriously difficult to treat with devasting outcomes. …
Pre-extensively drug-resistant tuberculosis among pulmonary multidrug-resistant tuberculosis patients in Eastern Nigeria.
Nwachukwu NO, Ulasi AE, Okoronkwo CU, Unegbu VN. Nwachukwu NO, et al. Lung India. 2023 Nov-Dec;40(6):492-495. doi: 10.4103/lungindia.lungindia_337_23. Lung India. 2023. PMID: 37961955 Free PMC article.
BACKGROUND: Pre-extensively drug-resistant tuberculosis (Pre-XDR-TB), an emerging form of drug-resistant tuberculosis, is challenging efforts at tuberculosis control, leading to treatment failure among multidrug-resistant tuberc …
BACKGROUND: Pre-extensively drug-resistant tuberculosis (Pre-XDR-TB), an emerging form of drug-resistant …
Drug Sensitivity Testing of Mycobacterium tuberculosis Growing in a Hollow Fiber Bioreactor.
Mason AB, Dartois V. Mason AB, et al. Methods Mol Biol. 2021;2314:715-731. doi: 10.1007/978-1-0716-1460-0_31. Methods Mol Biol. 2021. PMID: 34235677
The unique properties of the HFS are (1) the ability to simulate any PK profile within the fibers and ECS, including plasma or site-of-disease PK profiles, (2) the ability to simultaneously input several drugs with different half-lives, (3) the ability to manipulate growth condit …
The unique properties of the HFS are (1) the ability to simulate any PK profile within the fibers and ECS, including plasma or site-of-disea …
Clinical features, resistance patterns and treatment outcomes of drug-resistant extra-pulmonary tuberculosis: A scoping review.
Miiro E, Olum R, Baluku JB. Miiro E, et al. J Clin Tuberc Other Mycobact Dis. 2023 Aug 4;33:100390. doi: 10.1016/j.jctube.2023.100390. eCollection 2023 Dec. J Clin Tuberc Other Mycobact Dis. 2023. PMID: 37588726 Free PMC article. Review.
Studies which did not describe drug-resistance patterns at extra-pulmonary TB sites were excluded. We summarized the proportion of resistance to individual anti-TB drugs as well as multi-drug resistant (MDR), pre-extensively drug resistant …
Studies which did not describe drug-resistance patterns at extra-pulmonary TB sites were excluded. We summarized the proportio …
Pre-extensively drug-resistant tuberculosis spondylodiscitis in an immunocompetent patient: a case report.
Fellous S, Rkain H, Tahiri L, Bouraqadi A, Nassar I, Allali F. Fellous S, et al. Pan Afr Med J. 2020 Jul 8;36:165. doi: 10.11604/pamj.2020.36.165.21689. eCollection 2020. Pan Afr Med J. 2020. PMID: 32952809 Free PMC article.
Pre-extensively drug resistant tuberculosis (pre-XDR-TB) has been an area of growing concern, and posing a threat to global efforts of TB control. We report a case of PreXDR-TB spondylodiscitis with resistance to a Fluoroquinolone, in an immunoc …
Pre-extensively drug resistant tuberculosis (pre-XDR-TB) has been an area of growing concern, and posing …
607,505 results
You have reached the last available page of results. Please see the User Guide for more information.